These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29159179)

  • 1. miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.
    Wang N; Li Y; Zhou J
    Biomed Res Int; 2017; 2017():6361420. PubMed ID: 29159179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
    Yao J; Deng B; Zheng L; Dou L; Guo Y; Guo K
    Oncol Rep; 2016 Mar; 35(3):1645-51. PubMed ID: 26706910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
    Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
    Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
    Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.
    Kim J; Park S; Chang Y; Park KH; Lee H
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764455
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Zhang X; Cai D; Meng L; Wang B
    Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
    Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
    J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1.
    Yan L; Yu MC; Gao GL; Liang HW; Zhou XY; Zhu ZT; Zhang CY; Wang YB; Chen X
    J Cell Biochem; 2018 Nov; 119(11):8773-8783. PubMed ID: 30076753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
    Shen W; Xie XY; Liu MR; Wang LL
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
    Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
    Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
    Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X
    Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.
    Song J; Li Y
    Cancer Sci; 2017 Jan; 108(1):23-31. PubMed ID: 27743413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 suppresses lung cancer progression and is inhibited by miR-31.
    Yu M; Liang H; Fu Z; Wang X; Liao Z; Zhou Y; Liu Y; Wang Y; Hong Y; Zhou X; Yan X; Yu M; Ma M; Zhang W; Guo B; Zhang J; Zen K; Zhang CY; Wang T; Zhang Q; Chen X
    Oncotarget; 2016 Mar; 7(12):13742-53. PubMed ID: 26885612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.
    Li JH; Zhang Z; Du MZ; Guan YC; Yao JN; Yu HY; Wang BJ; Wang XL; Wu SL; Li Z
    Arch Biochem Biophys; 2018 Nov; 657():23-30. PubMed ID: 30222949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-150-5p promotes the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via targeting SRCIN1.
    Zhu J; Han S
    Pathol Res Pract; 2019 Apr; 215(4):738-747. PubMed ID: 30679084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma.
    Qu D; Yang Y; Huang X
    J Cell Biochem; 2019 Aug; 120(8):13562-13572. PubMed ID: 30937952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.